Actinic Keratosis Market Trends, Outlook, and
Opportunity Analysis, 2018 – 2026
Actinic keratosis (AK), referred as solar keratosis is a scaly and crusty growth caused by the
damage from exposure to ultraviolet (UV) radiation. These precancerous skin lesions appear on
the skin frequently exposed to the artificial sources of UV light, such as tanning machines or
the sun. The skin lesions appear elevated, rough textured, and resemble warts. Actinic keratosis
reflects abnormal skin cell development, due to DNA damage by short wavelength ultraviolet B
(UVB). Individuals working with polycyclic aromatic hydrocarbons (PAHs), such as coal or tar
are at a higher risk of getting AKs, as they are mostly exposed to the UV rays and tar. A small
percentage of actinic keratosis lesions have the potential to eventually culminate into a type of
skin cancer known as squamous cell carcinoma. Prevention of actinic keratosis is important, as
the condition can precede cancer or be an early form of skin cancer. Skin biopsy is indicated
for the conformation of the diagnosis and to eradicate invasive squamous cell carcinoma for the
advanced lesions.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1006
Increasing complications associated with actinic keratosis is expected to fuel the actinic keratosis
market
The treatment of actinic keratosis as a part of preventive strategy for the reduction of
interrelated disorders, such as non-melanoma skin cancer, squamous cell carcinoma, and basal
cell carcinoma is coming to the forefront. According to the U.S. National Library of Medicine,
2015, approximately 60% of squamous cell carcinomas of the skin probably arise from actinic
keratosis. Therefore, the rising incidences of skin cancers, such as intra epidermal squamous cell
carcinoma, invasive cutaneous squamous cell carcinoma, basal cell carcinoma, and melanoma is
expected to augment the market growth. Moreover, the wide presence and easy availability of
generic drugs for the treatment for actinic keratosis is expected to boost the market growth.
However, lack of medical awareness about the skin condition, available treatments, and delayed
diagnosis are some of the factors restraining the global actinic keratosis market.